Involvement of SRC-3 in deguelin-induced apoptosis in Jurkat cells

International Journal of Hematology

Volumn 89, Issue 5, 2009, Pages 628-635

  Li, Rui ^a   Chen, Yan ^a   Shu, Wen Xiu ^a   Chen, Zi ^a   Ke, Wen Juan ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Apoptosis; Deguelin; Leukemia; NF B; SRC 3

Indexed keywords

DEGUELIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BCL 2; PROTEIN BCL XL; STEROID RECEPTOR COACTIVATOR 3;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; IC 50; LEUKEMIA CELL LINE; NICK END LABELING; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; DOWN-REGULATION; HISTONE ACETYLTRANSFERASES; HUMANS; JURKAT CELLS; NF-KAPPA B; ROTENONE; TRANS-ACTIVATORS;

EID: 67749107960     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-009-0311-8     Document Type: Article

References (29)

1. CS Suen TJ Berrodin R Mastroeni BJ Cheskis CR Lyttle DE Frail 1998 A transcriptional coactivator, steroid receptor coactivator-3, selectively augments steroid receptor transcriptional activity J Biol Chem 16 27645 27653 10.1074/jbc.273.42.27645 (Pubitemid 28500489)
2. SJ Han FJ Demayo J Xu SY Tsai MJ Tsai BW O'Malley 2006 Steroid receptor coactivators SRC-1 and SRC-3 differentially modulate tissue-specific activation functions of the progesterone receptor Mol Endocrinol 20 45 55 10.1210/me.2005-0310 (Pubitemid 43011669)
3. H Ying F Furuya MC Willingham J Xu BW O'Malley SY Cheng 2005 Dual functions of the steroid hormone receptor coactivator 3 in modulating resistance to thyroid hormone Mol Cell Biol 25 7687 7695 10.1128/MCB.25.17.7687-7695.2005 (Pubitemid 41170130)
4. S Werbajh I Nojek R Lanz MA Costas 2000 RAC-3 is a NF-kappa B coactivator FEBS Lett 485 195 199 10.1016/S0014-5793(00)02223-7 (Pubitemid 30950536)
5. J Yan CT Yu M Ozen M Ittmann SY Tsai MJ Tsai 2006 Steroid receptor coactivator-3 and activator protein-1 coordinately regulate the transcription of components of the insulin-like growth factor/AKT signaling pathway Cancer Res 66 11039 11046 10.1158/0008-5472.CAN-06-2442 (Pubitemid 44877004)
6. NJ McKenna BW O'Malley 2002 Combinatorial control of gene expression by nuclear receptors and coregulators Cell 108 465 474 10.1016/S0092-8674(02)00641- 4 (Pubitemid 34260872)
7. D Chen H Ma H Hong SS Koh SM Huang BT Schurter 1999 Regulation of transcription by a protein methyltransferase Science 284 2174 2177 10.1126/science.284.5423.2174 (Pubitemid 29297477)
8. SL Anzick J Kononen RL Walker DO Azorsa MM Tanner XY Guan 1997 AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer Science 277 965 968 10.1126/science.277.5328.965 (Pubitemid 27366683)
9. MC Louie JX Zou A Rabinovich HW Chen 2004 ACTR/AIB1 functions as an E2F1 coactivator to promote breast cancer cell proliferation and antiestrogen resistance Mol Cell Biol 24 5157 5171 10.1128/MCB.24.12.5157-5171.2004 (Pubitemid 38738153)
10. MI Torres-Arzayus JF De Mora J Yuan F Vazquez R Bronson M Rue 2004 High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene Cancer Cell 6 263 274 10.1016/j.ccr.2004.06.027 (Pubitemid 39222039)
11. SQ Kuang L Liao H Zhang AV Lee BW O'Malley J Xu 2004 AIB1/SRC-3 deficiency affects insulin-like growth factor I signaling pathway and suppresses v-Ha-ras-induced breast cancer initiation and progression in mice Cancer Res 64 1875 1885 10.1158/0008-5472.CAN-03-3745 (Pubitemid 38428714)
12. HY Lee SH Oh JK Woo WY Kim CS Van Pelt RE Price 2005 Chemopreventive effects of deguelin, a novel Akt inhibitor, on tobacco-induced lung tumorigenesis J Natl Cancer Inst 97 1695 1699
13. R Bortul PL Tazzari AM Billi G Tabellini I Mantovani A Cappellini 2005 Deguelin, A PI3K/AKT inhibitor, enhances chemosensitivity of leukaemia cells with an active PI3K/AKT pathway Br J Haematol 129 677 686 10.1111/j.1365-2141. 2005.05504.x (Pubitemid 40825830)
14. B Geeraerts B Vanhoecke W Vanden Berghe J Philippé F Offner D Deforce 2007 Deguelin inhibits expression of IkappaB alpha protein and induces apoptosis of B-CLL cells in vitro Leukemia 21 1610 1618 10.1038/sj.leu.2404788 (Pubitemid 47086752)
15. WH Chen Y Chen GH Cui 2006 Deguelin inhibits expression of IkappaBalpha protein in Raji and U937 cells Acta Pharmacol Sin 27 485 490 10.1111/j.1745-7254.2006.00284.x
16. HL Liu Y Chen GH Cui QL Wu J He 2005 Regulating expressions of cyclin D1, pRb, and anti-cancer effects of deguelin on human Burkitt's lymphoma Daudi cells in vitro Acta Pharmacol Sin 26 873 880 10.1111/j.1745-7254.2005.00104.x (Pubitemid 40978771)
17. A Oh HJ List R Reiter A Mani Y Zhang E Gehan 2004 The nuclear receptor coactivator AIB1 mediates insulin-like growth factor I-induced phenotypic changes in human breast cancer cells Cancer Res 64 8299 8308 10.1158/0008-5472.CAN-04-0354 (Pubitemid 39491768)
18. RC Wu J Qin Y Hashimoto J Wong J Xu SY Tsai 2002 Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) coactivator activity by I kappa B kinase Mol Cell Biol 22 3549 3561 10.1128/MCB.22.10.3549-3561.2002 (Pubitemid 34453993)
19. BM Ghadimi E Schrock RL Walker D Wangsa A Jauho PS Meltzer 1999 Specific chromosomal aberrations and amplification of the AIB1 nuclear receptor coactivator gene in pancreatic carcinomas Am J Pathol 154 525 536
20. RT Henke BR Haddad SE Kim JD Rone A Mani JM Jessup 2004 Overexpression of the nuclear receptor coactivator AIB1 (SRC-3) during progression of pancreatic adenocarcinoma Clin Cancer Res 10 6134 6142 10.1158/1078-0432.CCR-04-0561 (Pubitemid 39287519)
21. C Sakakura A Hagiwara R Yasuoka Y Fujita M Nakanishi K Masuda 2000 Amplification and over-expression of the AIB1 nuclear receptor co-activator gene in primary gastric cancers Int J Cancer 89 217 223 10.1002/1097-0215(20000520) 89:3<217::AID-IJC2>3.0.CO;2-6 (Pubitemid 30430736)
22. Y Wang MC Wu JS Sham W Zhang WQ Wu XY Guan 2002 Prognostic significance of c-myc and AIB1 amplification in hepatocellular carcinoma: a broad survey using high-throughput tissue microarray Cancer 95 2346 2352 10.1002/cncr.10963 (Pubitemid 35351141)
23. H Li JD Chen 1998 The receptor-associated coactivator 3 activates transcription through CREB-binding protein recruitment and autoregulation J Biol Chem 273 5948 5954 10.1074/jbc.273.10.5948 (Pubitemid 28124075)
24. GP Colo RR Rosato S Grant MA Costas 2007 RAC3 down-regulation sensitizes human chronic myeloid leukemia cells to TRAIL-induced apoptosis FEBS Lett 581 5075 5081 10.1016/j.febslet.2007.09.052 (Pubitemid 47576089)
25. S Esteyries C Perot J Adelaide M Imbert A Lagarde C Pautas 2008 NCOA3, a new fusion partner for MOZ/MYST3 in M5 acute myeloid leukemia Leukemia 22 663 665 10.1038/sj.leu.2404930
26. AA Beg D Baltimore 1996 An essential role for NF-κB in preventing TNF-α-induced cell death Science 274 782 784 10.1126/science.274.5288.782 (Pubitemid 26398258)
27. E Pikarsky RM Porat I Stein R Abramovitch S Amit S Kasem 2004 NF-kappaB functions as a tumour promoter in inflammation-associated cancer Nature 23 461 466 10.1038/nature02924 (Pubitemid 39329586)
28. S Shishodia BB Aggarwal 2002 Nuclear factor-kappaB activation: a question of life or death J Biochem Mol Biol 35 28 40
29. GP Colo MF Rubio IM Nojek SE Werbajh PC Echeverra CV Alvarado 2008 The p160 nuclear receptor co-activator RAC3 exerts an anti-apoptotic role through a cytoplasmatic action Oncogene 27 2430 2444 10.1038/sj.onc.1210900